New Antimicrobials: For the Present and the Future

1. Antimicrobial Resistance: A crisis in the making.- 2: New Cephalosporins: 5th and 6th generations.- 3: New ?-lactam-?-lactamase inhibitor combinations.- 4: New Glycopeptides: Televancin, dalbavancin and oritavancin.- 5: A new fluoroquinolone-Delafloxacin.- 6: New Oxazolininone---Tedizolid.- 7: New Tetracyclines: Eravacycline and Omadacycline.- 8: Pleuromutilin: A new class of antibiotic: Lefamulin.- 9: New anti-tuberculous drugs: Bedaquiline, Delamanid and Pretomanid.- 10: New systemic antifungal: Isavuconazole.- 11: Newly approved anti-parasitic drugs for malaria, fascioliasis, onchocerciasis, Chagas disease and African trypanosomiasis.- 12:New antiretroviral agents for HIV infection.- 13: New Antiviral agents for cytomegalovirus diseases.- 14: New antiviral agent for influenza: Baloxavir.- 15: Direct antiviral agents for hepatitis C.- 16: Antiviral drugs for SARS-CoV-2 and COVID-19.- 17: New promising antimicrobials in development and novel approaches for treatment of infections.-

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Medicina interna e clínica
• Microbiologia e virologia médicas
• Imunologia

antimicrobial resistance;antimicrobial agents;antibiotic;antifungal;antiparasitic;systemic infection;newly developed;antiviral;pharmacokinetics;pharmacology;antimicrobial spectrum;WHO;WHO GLASS;WHO GARDP;IACG AMR